Seizure: European Journal of Epilepsy
Volume 17, Issue 6 , Pages 531-534, September 2008

Lamotrigine and catamenial epilepsy

Department of Neurology, Edith Wolfson Medical Center, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, 58100 Holon, Israel

Received 25 November 2006; received in revised form 1 October 2007; accepted 29 February 2008. published online 17 April 2008.

Summary 

Catamenial epilepsy (CE) is characterized by epileptic seizures in the female occurring rhythmatically with the menstrual cycle. Hormonal mechanisms have been proposed as a cause of this epileptic form. Few reports about the efficacy of anti-epileptic drugs (AEDs) have been published. We studied prospectively women with CE who were treated with lamotrigine (LTG) for a period of 3 months in order to evaluate its efficacy, measuring the progesterone levels before and after LTG at the same time. LTG seemed to be efficacious in 66% of women, meaning the disappearance of seizures or reduction of 50% or more of the number of seizures. The reported side effects were few and mild, and the drug was well tolerated. Serum progesterone levels were found to rise during LTG treatment.

Keywords: Lamotrigine, Epilepsy, Catamenial, Menstruation

 

PII: S1059-1311(08)00051-4

doi:10.1016/j.seizure.2008.02.001

Seizure: European Journal of Epilepsy
Volume 17, Issue 6 , Pages 531-534, September 2008